<DOC>
	<DOCNO>NCT01795144</DOCNO>
	<brief_summary>The purpose study explore mechanism metabolic control monogenic diabetes patient treat sulfonylurea medication .</brief_summary>
	<brief_title>Incretin Regulation Insulin Secretion Monogenic Diabetes</brief_title>
	<detailed_description>Monogenic diabetes patient healthy match control admit University Chicago Clinical Resource Center total 4 night . The follow take place separate day : 1 . Oral Glucose Tolerance Test ( OGTT ) : consume sugary drink blood sample collect multiple time point 2 . Isoglycemic glucose infusion ( IGI ) test : glucose infuse via vein arm blood sample collect multiple time point 3 . OGTT GLP-1 infusion 4 . IGI Exendin-9 infusion</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<criteria>Monogenic Diabetes Subjects : Diagnosis monogenic diabetes Previously participate US Neonatal Diabetes Registry ( IRB 15617B ) Genetics diabetes mellitus ( IRB 6858 ) Age : 18 year + Pregnancy Acute medical illness chronic condition include : cardiac failure , renal insufficiency ( estimate glomerular filtration rate &lt; 50 ml/min ) , hepatic insufficiency ( know cirrhosis hepatitis ) , chronic obstructive pulmonary disease , gastrointestinal disorder cause malabsorption , anemia ( Hct &lt; 36 % ) , uncontrolled hypertension Healthy Controls : Good general health Stable weight 6 month Age : 18 year + Pregnancy Acute medical illness chronic condition include : cardiac failure , renal insufficiency ( estimate glomerular filtration rate &lt; 50 ml/min ) , hepatic insufficiency ( know cirrhosis hepatitis ) , chronic obstructive pulmonary disease , gastrointestinal disorder cause malabsorption , anemia ( Hct &lt; 36 % ) , uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>